Launched in 2017, Fortis is one of a handful of public recovery high schools in the country. Every semester, it enrolls ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets TRBC2-positive T-cell cancers, expanding a precision approach they established ...

President Donald Trump’s move to reclassify marijuana as a less dangerous drug departs from the tenets of the Wyoming MAGA ...

In this article, we examine ongoing challenges shaping target-based drug discovery and highlight how new technologies and ...

Valink Therapeutics ("Valink"), a private biotechnology company developing next-generation therapeutics with a focus on bispecific antibody-drug conjugates (bsADCs) and complementary modalities, and ...

Nona Biosciences is a global biotechnology company committed to cutting-edge technology innovations and providing integrated solutions from I to I (R) (Idea to IND), ranging from target validation and ...

Doctors and researchers try to understand what medications a person has taken by asking patients directly or by looking at medical records. But this information is often incomplete. People may forget ...

Dr. Robert Orlowski says a single-drug option in newly diagnosed myeloma may offer strong responses with fewer side effects and preserve future treatments. Dr. Robert Orlowski presented updated ELARA ...

President Donald Trump's ultimatum to Venezuelan President Nicolás Maduro marks a new flashpoint in his comprehensive crackdown on drug trafficking, one that's garnering praise from a retired U.S.

New approach methodologies (NAMs) aim to address the limitations of animal models by assessing drug efficacy and safety in a more ethical, human-relevant way. The term ‘NAMs’ encompasses several ...